Male contraception topic of CBC Radio show The Current

Why don’t we have a male birth control pill?  What is the status of RISUG? Why is Vasalgel being promoted by a nonprofit instead of a pharmaceutical company? What are the attitudes of men and women on the topic of male birth control?  These topics were covered in a recent edition of The Current on CBC Radio. Host Anna Maria Tremonti interviewed experts to uncover the answers. Dr. Ronald Weiss, who was a member of the 2002 WHO panel to evaluate RISUG, explained that even though RISUG has been researched for decades, the product cannot be marketed in N. America because the studies were not done to international standards. Dr. Weiss indicated that Vasalgel can begin clinical trials after animal studies are conducted in the US. Tremonti concluded the show with an in depth discussion of whether men would be willing to take contraception and how women might respond.

Linda Brent, PhD

Executive Director, Parsemus Foundation

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to info@parsemus.org.
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today